YDWAF yields 9.73% · PFE yields 6.13%● Live data
📍 YDWAF pulled ahead of the other in Year 1
Combined, YDWAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YDWAF + PFE for your $10,000?
Yodogawa Steel Works, Ltd. manufactures and sells steel products for industrial and consumer products in Japan. The company offers steel sheets products comprising pre-painted and galvanized steel sheets, chromate-free treated steel sheets, cold rolled steel strips, special steel strips, steel strapping, and cold rolled steel sheets, as well as plated steel sheets, colored plated and printed steel sheets, and other types of steel sheets. It also provides exterior products for storage sheds, garages, carports, bicycle parks, warehouses, lodges, and trash bins; and building materials comprising roofing and siding, and environmental products. In addition, the company offers rolls for section steel, including plate and hot strip mill work rolls; paper manufacturing rolls; drilled rolls for rubber and vinyl; calendar equipment for paper making; and cast iron rollers and other types of rollers. Further, it provides high-function grating products, as well as other gratings products, including grating, and pit and U-shaped covers. Additionally, the company is involved in the design and contracting of construction work; warehousing, packaging, and shipping activities; and sale, purchase, and lease of real estate, as well as building of facilities and landscaping activities. Yodogawa Steel Works, Ltd. was incorporated in 1935 and is headquartered in Osaka, Japan.
Full YDWAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.